Red Bull’s slow start to the 2025 Formula 1 season has led to emergency meetings in the paddock to discuss a plan forward, and already prompted one driver switch. As well as speculation about the… Max Verstappen dismisses speculation about his Red Bull F1 future
Two new studies suggest that stem-cell treatments may be getting closer to becoming widely available for Parkinson’s patients. pocketlight/iStockphoto/Getty Images hide caption toggle caption pocketlight/iStockphoto/Getty Images Patients suffering from Parkinson’s disease may soon benefit from… Stem cells to treat Parkinson’s? 2 small studies hint at success : Shots
by Keka Araújo April 17, 2025 Puerto Rico Governor Jenniffer González-Colón called the transmission issue “unacceptable.” Crews are working to restore power to Puerto Rico after an island-wide blackout left 1.4 million customers in the… Pre-Easter Blackout Affects Millions, Restoration Underway In Puerto Rico
Image by Klara Kulikova It’s one of those questions that feels almost taboo to ask out loud: Do we actually owe our parents anything? For many people, the default response is yes. After all, they… Do You Really Owe Your Parents Anything?
Disclosure: Our goal is to feature products and services that we think you’ll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from our… The $50 Software That Could Save Your Business One Day
Apr 8, 2025; Oklahoma City, Oklahoma, USA; Los Angeles Lakers guard Luka Doncic (77), forward Jarred Vanderbilt (2), forward LeBron James (23), and guard Austin Reaves (15) talk to an official during a time out… NBA playoffs begin after chaotic season of shock player moves
What if you could give your weight loss journey a boost? GLP-1 receptor agonists are doctor-prescribed medications that facilitate weight loss by replicating a hormone that curbs your appetite. Their effectiveness is amplified when paired… Integrating GLP-1 In Your Holistic Health Plan
When was the last time you went on a trip and enjoyed the outdoors? As adults, reconnecting with nature becomes more difficult as responsibilities pile up. However, research shows that engaging with nature regularly helps… Basking in Nature Helps Relieve Stress and Improve Mood
Everyone’s comparing AI chatbots — but what happens when one of them is not a chatbot at all?
An index fund is a kind of passive investment that aims to mirror the performance of a specific index rather than trying to outperform it. Here we’ll look at what index mutual funds are, how… Index Funds – Meaning, Why and How You Should Invest?
The 2025 NBA Playoffs are here with three big favorites and a pool of contenders ready to play the spoiler. The Boston Celtics are trying to become the league’s first back-to-back champion since the 2017-2018… NBA Playoffs teams ranked by their 2025 championship chances
An application tracking system (ATS) is part of many organizations’ recruitment tech stack. Although they’re frequently seen in corporate settings, small businesses and mid-market companies also use them fairly extensively.
Image by Priscilla Du Preez Polyamory tends to spark strong reactions. For some, it’s seen as liberating—an honest approach to love that breaks free from outdated rules. For others, it raises eyebrows and invites assumptions,… Are Polyamorous People Just Afraid of Commitment—or More Emotionally Mature?
Last week, we marked an important milestone in our SMB journey with the first-ever EMEA SMB Partner Advisory Board-a dynamic and insightful gathering of 51 partners who joined us for two days of deep discussions,… A Milestone for Cisco SMB: The Inaugural EMEA SMB Partner Advisory Board
Ligand Pharmaceuticals Incorporated LGND and Channel Therapeutics Corporation CHRO on Thursday signed a definitive merger agreement to combine Ligand’s wholly owned subsidiaries, Pelthos Therapeutics Inc. and LNHC, Inc. (collectively Pelthos) with CHRO Merger Sub Inc.,… EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity – Ligand Pharmaceuticals (NASDAQ:LGND), Channel Therapeutics (AMEX:CHRO)